Article
Mutational status of PIK3ca oncogene in oral cancer-In the new age of PI3K inhibitors.
Pathology, research and practice - 1 Jan 2020
Denninghoff V, Muino A, Diaz M, Harada L, Lence A, Turon P, Labbrozzi M, Aguas S, Peñaloza P, Avagnina A, Adler I
Abstract excerpt
In the new age of PI3K inhibitors, the mutational status of PI3Kca oncogene in the Cavity Squamous Cell Carcinoma (OC-SCC) needs further analysis. It is the sixth most common cancer in the world. The aim of this study was to evaluate PI3Kca oncogene mutations and to correlate them with the clinical-histological characteristics of individuals presenting these tumors. We recruited 74 individuals with OC-SCC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
